Cardioprotective Effects of Intracoronary Morphine in ST‐Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: A Prospective, Randomized Trial
Open Access
- 5 April 2017
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Heart Association
- Vol. 6 (4), e005426
- https://doi.org/10.1161/jaha.116.005426
Abstract
Background: A cardioprotective role of morphine acting via opioid receptors has been demonstrated, and previous preclinical studies have reported that morphine could reduce reperfusion injury and myocardial infarct size in a way similar to that of ischemic periconditioning. This study aimed to evaluate the effect of intracoronary morphine on myocardial infarct size in patients with ST ‐elevation myocardial infarction undergoing primary percutaneous coronary intervention. Methods and Results: This study was designed as a 2‐center, prospective, randomized, open‐label, blinded end point trial. A total of 91 ST ‐elevation myocardial infarction patients with thrombolysis in myocardial infarction flow grade of 0 to 1 undergoing primary percutaneous coronary intervention were randomly assigned to a morphine or control group at a 1:1 ratio. The morphine group received 3 mg of morphine sulfate diluted with 3 mL of normal saline, and the control group received 3 mL of normal saline into a coronary artery immediately after restoration of coronary flow. The primary end point was myocardial infarct size assessed by cardiac magnetic resonance imaging The cardiac magnetic resonance images were evaluated for 42 and 38 patients in the morphine and control groups, respectively. Myocardial infarct size was not different between the 2 groups (25.6±11.2% versus 24.6±10.5%, P =0.77), nor was the extent of microvascular obstruction or myocardial salvage index (6.0±6.3% versus 5.1±4.6%, P =0.91; 31.1±15.2% versus 30.3±10.9%, P =0.75, respectively). There was no difference in peak creatine kinase‐ MB level, final thrombolysis in myocardial infarction flow, myocardial brush grade, or complete resolution of ST ‐segment. Conclusions: Intracoronary morphine administration could not reduce myocardial infarct size in ST ‐elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. Clinical Trial Registration: URL : http://www.clinicaltrials.gov . Unique identifier: NCT 01738100.Keywords
This publication has 34 references indexed in Scilit:
- Upstream High-Dose Tirofiban Does Not Reduce Myocardial Infarct Size in Patients Undergoing Primary Percutaneous Coronary Intervention: A Magnetic Resonance Imaging Pilot StudyClinical Cardiology, 2009
- Intracoronary Compared With Intravenous Bolus Abciximab Application in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary InterventionCirculation, 2008
- Cardioprotective Effect of Morphine and a Blocker of Glycogen Synthase Kinase 3β, SB216763 [3-(2,4-Dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione], via Inhibition of the Mitochondrial Permeability Transition PoreThe Journal of pharmacology and experimental therapeutics, 2008
- Myocardial Reperfusion InjuryThe New England Journal of Medicine, 2007
- The δ-opioid receptor agonist DADLE at reperfusion protects the heart through activation of pro-survival kinases via EGF receptor transactivationAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Pretreatment with intracoronary adenosine reduces the incidence of myonecrosis after non-urgent percutaneous coronary intervention: a prospective randomized studyEuropean Heart Journal, 2006
- Epidemiology of Heart Failure and Left Ventricular Systolic Dysfunction after Acute Myocardial Infarction: Prevalence, Clinical Characteristics, and Prognostic ImportanceThe American Journal of Cardiology, 2006
- Remodeling Characteristics of Minimally Diseased Coronary Arteries Are Consistent Along the Length of the ArteryThe American Journal of Cardiology, 2006
- Postconditioning: Reperfusion of “reperfusion injury” after hibernationCardiovascular Research, 2006
- Hemodynamic and metabolic effects of morphine in the critically ill.Circulation, 1981